Schedule 13G ownership disclosure

CHINA SXT PHARMACEUTICALS IN

Security class unavailable · CUSIP: G2161P140

Event date: 2024-05-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
42.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-066985
Form type
SC 13G/A
Filer
China SXT Pharmaceuticals, Inc.
CIK
CIK 1723980
Filed
May 31, 2024
Reporting period
May 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub